Numerous inflammatory mediators in the peripheral circulation, such as C-reactive protein (CRP) and interleukin-6 (IL-6), are altered in the acute phase of stroke and could have a role as biomarkers of prognosis or impending complications4,5. This evidence concerns the gene CRP and stroke disorder.